IL107987A - Dolastatin analogs their preparation and pharmaceutical compositions containing them - Google Patents

Dolastatin analogs their preparation and pharmaceutical compositions containing them

Info

Publication number
IL107987A
IL107987A IL10798793A IL10798793A IL107987A IL 107987 A IL107987 A IL 107987A IL 10798793 A IL10798793 A IL 10798793A IL 10798793 A IL10798793 A IL 10798793A IL 107987 A IL107987 A IL 107987A
Authority
IL
Israel
Prior art keywords
alkyl
alkoxy
substituted
nitro
substituents
Prior art date
Application number
IL10798793A
Other languages
English (en)
Other versions
IL107987A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL107987A0 publication Critical patent/IL107987A0/xx
Publication of IL107987A publication Critical patent/IL107987A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Window Of Vehicle (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL10798793A 1992-12-16 1993-12-10 Dolastatin analogs their preparation and pharmaceutical compositions containing them IL107987A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99130992A 1992-12-16 1992-12-16

Publications (2)

Publication Number Publication Date
IL107987A0 IL107987A0 (en) 1994-04-12
IL107987A true IL107987A (en) 1999-10-28

Family

ID=25537082

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10798793A IL107987A (en) 1992-12-16 1993-12-10 Dolastatin analogs their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US5502032A (cs)
EP (1) EP0674652B1 (cs)
JP (1) JPH08504415A (cs)
CN (1) CN1057095C (cs)
AT (1) ATE196296T1 (cs)
AU (1) AU679479B2 (cs)
BR (1) BR1100019A (cs)
CA (1) CA2151953A1 (cs)
CZ (1) CZ286752B6 (cs)
DE (1) DE69329425T2 (cs)
ES (1) ES2151921T3 (cs)
FI (1) FI952961A7 (cs)
HR (1) HRP931504B1 (cs)
HU (1) HUT72067A (cs)
IL (1) IL107987A (cs)
NO (1) NO952366L (cs)
NZ (1) NZ258882A (cs)
PL (1) PL178766B1 (cs)
RU (1) RU2132334C1 (cs)
SG (1) SG67935A1 (cs)
SI (1) SI9300661A (cs)
TW (1) TW400335B (cs)
WO (1) WO1994013695A1 (cs)
ZA (1) ZA939389B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599902A (en) * 1994-11-10 1997-02-04 Arizona Board Of Regents Acting On Behalf Of Arizona State University Cancer inhibitory peptides
US5663149A (en) * 1994-12-13 1997-09-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US5741892A (en) * 1996-07-30 1998-04-21 Basf Aktiengesellschaft Pentapeptides as antitumor agents
US5939527A (en) * 1996-07-30 1999-08-17 Basf Aktiengesellschaft Tetrapeptides as antitumor agents
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6103698A (en) 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US6015790A (en) * 1997-10-06 2000-01-18 Basf Aktiengesellschaft Methods and compositions for treating rheumatoid arthritis
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
EP1156803A4 (en) 1999-02-09 2004-03-17 Bristol Myers Squibb Co FXA LACTAM INHIBITORS AND METHOD
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
HUP0304058A2 (hu) 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
CA2463724A1 (en) * 2001-10-16 2003-04-24 Structural Bioinformatics Inc. Organosulfur inhibitors of tyrosine phosphatases
US7087604B2 (en) 2002-03-08 2006-08-08 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
BRPI0409721A (pt) * 2003-05-12 2006-05-02 Pfizer Prod Inc compostos de isoxazol e isotiazol para o tratamento de distúrbios neurodegenerativos
EP1765332A2 (en) * 2004-06-17 2007-03-28 Cengent Therapeutics, Inc. Trisubstituted nitrogen modulators of tyrosine phosphatases
WO2006017124A2 (en) * 2004-07-09 2006-02-16 Cengent Therapeutics, Inc. Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
EP1841749A1 (en) * 2004-09-02 2007-10-10 Metabasis Therapeutics, Inc. Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
JP5171621B2 (ja) * 2005-07-07 2013-03-27 シアトル ジェネティックス， インコーポレイテッド フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物
WO2012171020A1 (en) 2011-06-10 2012-12-13 Mersana Therapeutics, Inc. Protein-polymer-drug conjugates
US10226535B2 (en) 2012-12-10 2019-03-12 Mersana Therapeutics, Inc. Auristatin compounds and conjugates thereof
PL2968440T3 (pl) 2013-03-15 2019-12-31 Zymeworks Inc. Związki cytotoksyczne i antymitotyczne oraz sposoby ich stosowania
AU2014373640B2 (en) 2013-12-27 2018-08-30 Var2 Pharmaceuticals Aps VAR2CSA-drug conjugates
RU2729194C2 (ru) 2013-12-27 2020-08-05 Займворкс Инк. Сульфонамидсодержащие связывающие системы для лекарственных конъюгатов
AU2015318556C1 (en) 2014-09-17 2021-01-07 Zymeworks Bc Inc. Cytotoxic and anti-mitotic compounds, and methods of using the same
US10517958B2 (en) 2016-10-04 2019-12-31 Zymeworks Inc. Compositions and methods for the treatment of platinum-drug resistant cancer
MX2024002571A (es) 2021-09-03 2024-03-20 Toray Industries Composicion farmaceutica para tratamiento y/o prevencion de cancer.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3540495A1 (de) * 1985-11-15 1987-05-21 Merck Patent Gmbh Aminosaeurederivate
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
JP2714402B2 (ja) * 1988-07-13 1998-02-16 日清製粉株式会社 癌転移抑制剤
EP0357332A3 (en) * 1988-08-24 1991-07-31 Merck & Co. Inc. Renin inhibitors useful for the treatment of aids by inhibition of hiv protease
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
US5138036A (en) * 1989-11-13 1992-08-11 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
DE69232552T2 (de) * 1991-08-09 2002-10-31 Teikoku Hormone Mfg. Co., Ltd. Tetrapeptide Derivat

Also Published As

Publication number Publication date
HRP931504B1 (en) 2001-04-30
BR1100019A (pt) 2000-07-25
DE69329425T2 (de) 2001-01-18
WO1994013695A1 (en) 1994-06-23
FI952961A0 (fi) 1995-06-15
JPH08504415A (ja) 1996-05-14
CZ157595A3 (en) 1996-01-17
AU679479B2 (en) 1997-07-03
ZA939389B (en) 1995-06-15
IL107987A0 (en) 1994-04-12
US5502032A (en) 1996-03-26
CA2151953A1 (en) 1994-06-23
FI952961L (fi) 1995-06-15
RU95115135A (ru) 1997-06-10
NO952366D0 (no) 1995-06-15
AU5695994A (en) 1994-07-04
ES2151921T3 (es) 2001-01-16
CN1095724A (zh) 1994-11-30
EP0674652B1 (en) 2000-09-13
CN1057095C (zh) 2000-10-04
DE69329425D1 (de) 2000-10-19
SG67935A1 (en) 1999-10-19
HRP931504A2 (en) 1997-02-28
ATE196296T1 (de) 2000-09-15
NZ258882A (en) 1997-06-24
PL309353A1 (en) 1995-10-02
HU9501754D0 (en) 1995-08-28
FI952961A7 (fi) 1995-06-15
HUT72067A (en) 1996-03-28
TW400335B (en) 2000-08-01
EP0674652A1 (en) 1995-10-04
PL178766B1 (pl) 2000-06-30
SI9300661A (en) 1994-06-30
CZ286752B6 (en) 2000-06-14
RU2132334C1 (ru) 1999-06-27
NO952366L (no) 1995-06-15

Similar Documents

Publication Publication Date Title
AU679479B2 (en) Dolostatin analog
AU725164B2 (en) Novel dolastatin derivatives, their preparation and use
EP0642530B1 (en) Derivatives of dolastatin
CA2237721C (en) Antineoplastic peptides
AU775090B2 (en) Antineoplastic peptides
HK1080871A (en) Antineoplastic peptides
SK165497A3 (en) Peptides, preparation method thereof and pharmaceutical composition containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed